Dr. Varun Monga, MD
Claim this profileUniversity of Iowa Hospitals and Clinics
Studies Soft Tissue Sarcoma
Studies Cancer
17 reported clinical trials
26 drugs studied
Area of expertise
1Soft Tissue Sarcoma
Stage IV
Stage III
Stage II
2Cancer
Stage IV
Stage III
NTRK positive
Affiliated Hospitals
Clinical Trials Varun Monga, MD is currently running
Multiple Targeted Therapies
for Meningioma
This trial studies four drugs to treat patients with worsening meningioma. These drugs work by blocking enzymes that the tumor cells need to grow. The trial focuses on patients whose tumors have specific genetic mutations.
Recruiting1 award Phase 210 criteria
Immunotherapy + Chemotherapy
for Sarcoma
This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Doxorubicin is in a class of medications called anthracyclines. Doxorubicin damages the cell's deoxyribonucleic acid (DNA) and may kill tumor cells. It also blocks a certain enzyme needed for cell division and DNA repair. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding immunotherapy (pembrolizumab) to the standard chemotherapy (doxorubicin) may help patients with metastatic or unresectable DDLPS, UPS or a related poorly differentiated sarcoma live longer without having disease progression.
Recruiting2 awards Phase 310 criteria
More about Varun Monga, MD
Clinical Trial Related1 year of experience running clinical trials · Led 17 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Varun Monga, MD has experience with
- Temozolomide
- Abemaciclib
- Radiotherapy
- Ascorbate
- Radiation Therapy
- Pembrolizumab
Breakdown of trials Varun Monga, MD has run
Soft Tissue Sarcoma
Cancer
Brain Tumor
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Varun Monga, MD specialize in?
Varun Monga, MD focuses on Soft Tissue Sarcoma and Cancer. In particular, much of their work with Soft Tissue Sarcoma has involved Stage IV patients, or patients who are Stage III.
Is Varun Monga, MD currently recruiting for clinical trials?
Yes, Varun Monga, MD is currently recruiting for 3 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Varun Monga, MD has studied deeply?
Yes, Varun Monga, MD has studied treatments such as Temozolomide, Abemaciclib, Radiotherapy.
What is the best way to schedule an appointment with Varun Monga, MD?
Apply for one of the trials that Varun Monga, MD is conducting.
What is the office address of Varun Monga, MD?
The office of Varun Monga, MD is located at: University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 United States. This is the address for their practice at the University of Iowa Hospitals and Clinics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.